DNM3 and genetic modifiers of age of onset in LRRK2 Gly2019Ser parkinsonism: a genome-wide linkage and association study-Reference-Cited by-同舟云学术

DNM3 and genetic modifiers of age of onset in LRRK2 Gly2019Ser parkinsonism: a genome-wide linkage and association study

Published:2016-11 Issue:12 Volume:15 Page:1248-1256
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Trinh Joanne,Gustavsson Emil K,Vilariño-Güell Carles,Bortnick Stephanie,Latourelle Jeanne,McKenzie Marna B,Tu Chelsea Szu,Nosova Ekaterina,Khinda Jaskaran,Milnerwood Austen,Lesage Suzanne,Brice Alexis,Tazir Meriem,Aasly Jan O,Parkkinen Laura,Haytural Hazal,Foroud Tatiana,Myers Richard H,Sassi Samia Ben,Hentati Emna,Nabli Fatma,Farhat Emna,Amouri Rim,Hentati Fayçal,Farrer Matthew J

Publisher

Elsevier BV

Subject

Neurology (clinical)

Reference41 articles.

1. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology;Zimprich;Neuron,2004

2. Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations;Kachergus;Am J Hum Genet,2005

3. Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study;Ross;Lancet Neurol,2011

4. Low disease risk in relatives of north african lrrk2 Parkinson disease patients;Troiano;Neurology,2010

5. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study;Healy;Lancet Neurol,2008

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson’s disease study;Brain;2024-08-01

2. Genetic Modifiers of LRRK2 Parkinson's Disease: A Replication Study in Arab‐Berbers;Movement Disorders;2024-01-31

3. Parkinson’s Families Project: a UK-wide study of early onset and familial Parkinson’s disease;2023-12-05

4. Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association study;The Lancet Neurology;2023-11

5. Immunological characterization and diagnostic models of RNA N6-methyladenosine regulators in Alzheimer's disease;Scientific Reports;2023-09-04